Source:http://linkedlifedata.com/resource/pubmed/id/21388972
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-5-10
|
pubmed:abstractText |
The functional interaction between integrin ?6?4 and growth factor receptors has been implicated in key signaling pathways important for cancer cell function. However, few attempts have been made to selectively target this interaction for therapeutic intervention. Previous studies showed that curcumin, a yellow pigment isolated from turmeric, inhibits integrin ?6?4 signaling important for breast carcinoma cell motility and invasion, but the mechanism is not currently known. To address this issue, we tested the hypothesis that curcumin inhibits the functional interaction between ?6?4 and the epidermal growth factor receptor (EGFR). In this study, we found that curcumin disrupts functional and physical interactions between ?6?4 and EGFR, and blocks ?6?4/EGFR-dependent functions of carcinoma cells expressing the signaling competent form of ?6?4. We further showed that curcumin inhibits EGF-dependent mobilization of ?6?4 from hemidesmosomes to the leading edges of migrating cells such as lammelipodia and filopodia, and thereby prevents ?6?4 distribution to lipid rafts where functional interactions between ?6?4 and EGFR occur. These data suggest a novel paradigm in which curcumin inhibits ?6?4 signaling and functions by altering intracellular localization of ?6?4, thus preventing its association with signaling receptors such as EGFR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Curcumin,
http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Integrin alpha6beta4,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1538-8514
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
883-91
|
pubmed:meshHeading |
pubmed-meshheading:21388972-Antineoplastic Agents,
pubmed-meshheading:21388972-Carcinoma,
pubmed-meshheading:21388972-Cell Line, Tumor,
pubmed-meshheading:21388972-Curcumin,
pubmed-meshheading:21388972-Epidermal Growth Factor,
pubmed-meshheading:21388972-Hemidesmosomes,
pubmed-meshheading:21388972-Humans,
pubmed-meshheading:21388972-Integrin alpha6beta4,
pubmed-meshheading:21388972-Membrane Microdomains,
pubmed-meshheading:21388972-Protein Binding,
pubmed-meshheading:21388972-Protein Transport,
pubmed-meshheading:21388972-Pseudopodia,
pubmed-meshheading:21388972-Receptor, Epidermal Growth Factor,
pubmed-meshheading:21388972-Signal Transduction
|
pubmed:year |
2011
|
pubmed:articleTitle |
Curcumin inhibition of the functional interaction between integrin ?6?4 and the epidermal growth factor receptor.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71103, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|